Pharmacogenomic Discovery to Function and Mechanism: Breast Cancer as a Case Study.

about

Pharmacogenomic Discovery to Function and Mechanism: Breast Cancer as a Case Study.

Item

http://www.wikidata.org/entity/Q47755674

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Pharmacogenomic Discovery to Function and Mechanism: Breast Cancer as a Case Study.

@en

Pharmacogenomic Discovery to Function and Mechanism: Breast Cancer as a Case Study.

@nl

type

Item

label

Pharmacogenomic Discovery to Function and Mechanism: Breast Cancer as a Case Study.

@en

Pharmacogenomic Discovery to Function and Mechanism: Breast Cancer as a Case Study.

@nl

prefLabel

Pharmacogenomic Discovery to Function and Mechanism: Breast Cancer as a Case Study.

@en

Pharmacogenomic Discovery to Function and Mechanism: Breast Cancer as a Case Study.

@nl

P1476

Pharmacogenomic Discovery to Function and Mechanism: Breast Cancer as a Case Study.

@en

P2093

James Ingle

http://www.w3.org/2001/XMLSchema#string

Liewei Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity

Cancer statistics, 2015

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes

Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase.

Drug reactions enzymes, and biochemical genetics.

Characterization of the common genetic defect in humans deficient in debrisoquine metabolism.

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer

P304

243-252

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CPT.915

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

Richard Weinshilboum

P577

2017-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29052219

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics

P932

5760458

http://www.w3.org/2001/XMLSchema#string